• Tidak ada hasil yang ditemukan

Korelasi Ekspresi Cyclooxygenase-2 Dengan Microvessel Density Pada Karsinoma Nasofaring Di RSUP H. Adam Malik Medan

N/A
N/A
Protected

Academic year: 2019

Membagikan "Korelasi Ekspresi Cyclooxygenase-2 Dengan Microvessel Density Pada Karsinoma Nasofaring Di RSUP H. Adam Malik Medan"

Copied!
7
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

Asahara, T, Masuda, H, Takahashi T, Kalka, C, Pastore, C, Silver, M, Kearne, M, Magner, M, Isner, JM 1999, ‘Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization’ Circulation Research. 85 (3) pp.221-228.

Agulnik, M & Siu, LL 2005, ‘State of the Art Management of Nasopharyngeal Carcinoma : Current and Future Directions’ British Journal of Cancer. 92 pp. 799-806.

Andrianto Y 2008, Peranan Pemeriksaan Immunohistokimia COX-2 pada Karsinoma Nasofaring. Tesis. Bagian Patologi Anatomi Fakultas Kedokteran Universitas Sumatera Utara. Medan.

Bono, AV, Celato, N, Cova, VM, Salvadore, M, Chinetti, S, & Novario, R 2002, ‘Microvessel density in Prostate Carcinoma’ Prostate Cancer and Prostatic Disease. 5 pp. 123-127.

Brennan, B 2006, ‘Nasopharyngeal Carcinoma’ Orphanet Journal of Rare Diseases.1 (23) pp.1-5.

Chew, CT 1997, ‘Nasopharynx (The Postnasal Space)’ In : Hibbert, J. (ed)

Laryngology and Head and Neck Surgery Scott-Brown’s

Otolaryngology. 6th ed. London: Butterworth Heinemann. pp. 5/13/1-29.

Chien, CR, Chen, SW, Hsieh, CY & Liang, JA 2001, ‘Retrospective comparison of the AJCC, 5 th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition. An experience in Taiwan’

Japanese Journal of Clinical Oncology. 31(8) pp.363-9.

Cho, WC, 2007 ‘Nasopharyngeal carcinoma : Molecular biomarker discovery and progress’ Molecular Cancer. 6 (1) pp.1-9.

(2)

lymphangiogenic microvessel density in Breast Carcinoma : Correlation with Clinicopathologic Parameters and VEGF Family Gene Expression’

Modern Pathology. 18 pp.143-152.

Choy H & Milas L 2003, ‘Enhancing Radiotherapy with Cyclooxygenase-2 Enzym Inhibitors: A Rational Advance?. Journal of the National Cancer Institute. 95 (19): 1440-52.

Clària, J. 2003, ‘Cyclooxygenase-2 Biology’ Current Pharmaceutical Design. 9. pp. 2177-2190

stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment’ Clin Invest.. 113(7) pp.1040-50.

Divvela, AKC, Challa, SR & Tagaram, IK 2010, ‘Pathogenic role of Cyclooxygenase-2 in Cancer’, Journal of Health Science, vol. 56, no.5, pp. 502-516.

El-Shahat, ME, Lotfy, M, Fahmy, L, Abouel-Nour, MF, and EL-Kenawy, AE 2004, ‘Prognostic Value of Microvessel Density, Matrix Metalloproteinase-9 and p53 Protein Expression in Esophageal Cancer’ Journal of the Egyptian Nat. Cancer.16(4) pp.224-230.

Evoric, BM, ‘Quantitation of Microvessel density in Squamous Cell Carcinoma of the Head and Neck by Computer-aided Image Analysis’ Wien Klin Wochenschr. 117 (1)-20 pp. 53-57.

(3)

Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V 2001, ‘Cyclooxygenase-2 Pathway Correlates with VEGF Expression in Head and Neck Cancer. Implications for Tumor Angiogenesis and Metastasis’. Neoplasia. 3 (1): 53-61.

Guang-Wu, H, Sunagawa, M, Jie-En, L, Shimada, S, Gang, Z, Tokeshi, Y & Kosugi, T 2000, ‘The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF) and the extension of nasopharyngeal carcinoma’, The laryngoscope, vol. 110, pp. 2066-2069.

Guigay, J, Temam, S, Bourhis, J, Pignon, JP. & Armand, JP 2006, ‘Nasopharyngeal Carcinoma and Therapeutic Management: The Place of Chemotherapy’ Annals of Oncology.17 (10) pp. 304-307.

Guyton, AC & Hall, JE 1996, Textbook of Medical Physiology. 9th ed. Philadelphia : WB Saunders Company. pp. 199-208.

Harahap, MPH 2009, Ekspresi Vascular Endothelial Growth Factor Pada Karsinoma Nasofaring. Tesis. Universitas Sumatera Utara.

Her, C 2001 ‘Nasopharyngeal Cancer and the Southeast Asian Patient’

American Family Physician. 63 (9) pp.1776-1780.

Jeyakumar, A, Brickman, TM, Jeyakumar, A, & Doerr, T 2006, ‘Review of Nasopharyngeal Carcinoma’ Ear, Nose and Throat Journal. 85 (3) pp.168-184.

Ji, B, Liu, Y, Zhang, P, Wang, Y, Wang G. 2012, ‘COX-2 Expression and Tumor Angiogenesis in Thyroid Carcinoma Patients among Northeast Chinese Population-Result of a Single-Center Study’ International Journal of Medical Sciences. 9(3) pp. 237-242

Kumar, S 2003, ‘Epidemiological and Etiological Factors Associated with Nasopharyngeal Carcinoma. ICMR Bulletin. 33 (9) pp.1-9.

(4)

Leahy, KM, Koki, AT and Masferrer, JL. 2000 ‘Role of Cyclooxygenases in Angiogenesis’ Medicinal Chemistry.7. pp. 1163-1170

Levita J, Istyastono EP, Nawawi A, Mutholib A, Esch IJP & Ibrahim S. 2009 Analyzing the Interaction of Andrographolide and Neoandrographolide, Diterpenoid Compounds From Andrographis Paniculata (Burm.F) nees, to Cyclooxygenase-2 Enzyme by Docking Simulation’. ITB J. Sci.41 A (2): 110-9.

Lin, JC,Chen, KY, Wang, WY, Jan, JS Liang, WM & Wei, YH 2002, ‘Evaluation of cytokeratine 19 mRNA as a tumor marker in the periheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy’ Int. J. Cancer, 97, pp. 548-53.

Mandriota, SJ, Jussila, L, Jeltsch, M, Compagni, A, Baetens, D, Prevo, R, Banerji, S, Huarte, J, Montesano, R, Jackson, DG, Orci, L, Alitalo, K, Christofori, G & Pepper, MS 2001, ‘Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis’, EMBO Journal, vol. 20, no. 4, pp. 672-682.

Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M 2001, ‘Induction of Cyclooxygenase-2 by Epstein - Barr virus Latent Membrane Protein 1 is involved in Vascular Endothelial Growth Factor Production in Nasopharyngeal Carcinoma Cells’. PNAS. 98 (12): 6905-10.

‘COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome’, Appl Immunohistochem Mol Morphol, vol.15, no.3, pp. 255-9.

Natonal Comprehensive Cancer Network. 2010. NCCN Clinical Practise Guidelines in Oncology Head And Neck Cancer.

(5)

Pang RWC. & Poon, RTP 2006, ‘Clinical Implications of Angiogenesis in Cancers’ Vascular Health and Risk Management. 2 (2) pp. 97-108. Poon, RT, Ng, IO, Lau, C, Yu, W, Yang, Z, Fan, S and Wong, J 2002,

‘Tumor microvessel density as a Predictor Recurrence After Resection of Hepatocellular Carcinoma : A Prospective Study’ Journal of Clinical Oncology. 20 (7) pp. 1775 – 1785.

Puspitasari, D 2011 Gambaran Karsinoma Nasofaring di RSUP H. Adam Malik Medan Tahun 2006-2010. Tesis. Universitas Sumatera Utara. Rao, VUS, Shenoy, AM, & Karthikeyan, B 2011, ‘Role of angiogenetic

markers to predict neck node metastasis in head and neck’ J Cancer Res Ther. 6(2) pp. 142-6.

Rishikesh MK & Sadhana SS 2003, ‘Protaglandins and Cyclooxygenase: Their Probable Role in Cancer’. Indian Journal of Pharmacology. 35: 3-12.

Roychowdhury, DF, Tseng, A, Fu, KK, Weinberg, V, & Weidner, N 1996, ‘New Prognostic Factors in Nasopharyngeal Carcinoma’. American Cancer Society. 77 (8) pp. 1419- 1426.

Rubio, L, 2002, ‘Expression of p53 Protein and Tumor Angiogenesis as Prognostic Factors in Nasopharyngeal Carcinoma Patients. Pathol Rest Prac. 198 (2) pp. 97-102.

Siregar, SM 2010, Hubungan EBNA-1 dengan Karsinoma Nasofaring di RSUP H. Adam Malik Medan. Tesis. Universitas Sumatera Utara.

Sobolewski, C, Cerella, C, Dicato, M, Ghibelli, L, Diederich, M. 2010.’ The Role of Cyclooxygenase-2 inCell Proliferation and Cell Death in Human Malignancies. International Journal of Cell Biologi. pp.1-21.

(6)

Segawa Y, Yamamoto H, Shiratsuchi H, Hirakawa N, Komune S & Tsuneyoshi M 2009, ‘Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal

carcinoma’

Sudyartono, T & Wiratno 1996, ‘Manifestasi Klinik sebagai Dasar Diagnosis Karsinoma Nasofaring. PIT PERHATI. Malang: PERHATI, pp. 841-859.

Tae, K, El-Naggar, AK, Yoo, E, Feng, L, Lee, JJ, Hong, WK, Hittelman, WN, Shin, DM 2000,Expression of Vascular Endothelial Growth Factor and Microvessel Density in Head and Neck Tumorigenesis’.

Clinical Cancer Research. 6 pp. 2821–2828

nasopharyngeal carcinoma: immunohistochemical findings and potential implications’ J Clin Pathol.58(5) pp. 535–8

Taweevisit, M, Keelawat, S & Thoner PS 2010, ‘Correlation of Microvascular Density and Proliferation Index in Undifferentiated Nasopharyngeal Carcinoma. Asian Biomedicine, 4 (2) pp. 315-321. Uzzan, B, Nicholas, P, Cucherat M, & Perret, GI 2004, ‘Microvessel

density as A Prognostic Factor in Women with Breast Cancer : A Systematic Review of the Literature and Meta-Analysis. Cancer researches. 64 pp. 2941-2955.

Wei, WI 2006, ‘Nasopharyngeal Cancer’ In : Bailey, B.J., Johnson, J.T., Newlands, S.D. (eds) Head & Neck Surgery Otolaryngology. 4th ed. Philadelphia: Lippincott Williams & Wilkins. pp. 1657-1671.

Weidner N, Semple JP, Welch WR & Folkman J 1991, ‘Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma’ The new England journal of medicine. 324(1) pp. 1-7.

(7)

Wu, AW, Gu, J, Li, ZF, Ji, JF, Xu, GW 2004, ‘COX-2 expression and tumor angiogenesis in colorectal cancer World J Gastroenterol. 10(16) pp. 2323-2326

Cyclooxygenase-2 in Nasopharyngeal Carcinoma and Its Relation to

Angiogenesis and Prognosis’.

5(2) , pp. 104-107.

Yeh, SA, Tang, Y, Lui, CC, & Huang, EY 2006, ‘Treatment Outcomes of Patients with AJCC Stage IVC Nasopharyngeal Carcinoma: Benefits of Primary Radiotherapy. Jpn J Clin Onco. 36 (3) pp. 132-136.

Zhao, HC, Qin, R, Chen, X, Sheng, X, Wu, J, Wang, D, Chen GH 2006, ‘Microvessel density is a Prognostic Marker of Human Gastric Cancer’

Referensi

Dokumen terkait

Sampel paling banyak ditemukan pada laki-laki (73,3%), kelompok umur terbanyak adalah 41-60 tahun (60,0%), jenis histopatologi terbanyak adalah karsinoma sel skuamosa

Kentjono, WA 2003, Perkembangan terkini penatalaksanaan karsinoma nasofaring. 4th edition, New

Anggota Divisi Pengabdian Masyarakat SCOPH PEMA FK USU 2014 - 2015.. Universitas

Dalam penelitian ini Bapak/Ibu akan menjalani pemeriksaan jaringan (biopsi) yang diambil dari belakang hidung untuk memastikan diagnosis dan jenis kanker bagian belakang hidung,

Dalam penelitian ini Bapak/Ibu akan menjalani pemeriksaan jaringan (biopsi) yang diambil dari belakang hidung untuk memastikan diagnosis dan jenis kanker bagian belakang hidung,

Gambar 4: Jalur transduksi sinyal dan jaringan komunikasi silang antara gen tumor supresor yang terlibat pada karsinoma nasofaring. Penelitian di Cina tahun 2010, pada

Sampel paling banyak ditemukan pada laki-laki (73,3%), kelompok umur terbanyak adalah 41-60 tahun (60,0%), jenis histopatologi terbanyak adalah karsinoma sel skuamosa

Domain D adalah domain docking untuk kofaktor sedangkan Domain E/F atau disebut Ligan Binding Domain (LBD) adalah domain yang bertanggung jawab atas kekhususan ligan dan